Breaking: Venture Life Group (LON:VLG) Buy Rating Reiterated by Analysts at Northern Trust Capital Markets Today; The TP is Set to GBX 100.00

June 18, 2018 - By Adrian Erickson

Venture Life Group (LON:VLG) Rating Reaffirmed

London: In analysts report revealed to clients and investors on 18 June, Northern Trust Capital Markets reiterated their Buy rating on Venture Life Group (LON:VLG) shares. They now have a GBX 100.00 PT on the company. Northern Trust Capital Markets’s target would suggest a potential upside of 140.96 % from the company’s last stock price.

The stock increased 6.33% or GBX 2.5 during the last trading session, reaching GBX 42. About 82,197 shares traded or 231.83% up from the average. Venture Life Group Plc (LON:VLG) has 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. The company has market cap of 15.47 million GBP. It operates through Brands, and Development and Manufacturing divisions. It currently has negative earnings. The firm offers Benecol, a cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: